You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 57 No. 4, April 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (49)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Psychiatry, Other
 •Alert me on articles by topic

Methadone Dose Increase and Abstinence Reinforcement for Treatment of Continued Heroin Use During Methadone Maintenance

Kenzie L. Preston, PhD; Annie Umbricht, MD; David H. Epstein, PhD

Arch Gen Psychiatry. 2000;57:395-404.

Background  Although methadone maintenance is an effective therapy for heroin dependence, some patients continue to use heroin and may benefit from therapeutic modifications. This study evaluated a behavioral intervention, a pharmacological intervention, and a combination of both interventions.

Methods  Throughout the study all patients received daily methadone hydrochloride maintenance (initially 50 mg/d orally) and weekly counseling. Following baseline treatment patients who continued to use heroin were randomly assigned to 1 of 4 interventions: (1) contingent vouchers for opiate-negative urine specimens (n=29 patients); (2) methadone hydrochloride dose increase to 70 mg/d (n=31 patients); (3) combined contingent vouchers and methadone dose increase (n=32 patients); and (4) neither intervention (comparison standard; n=28 patients). Methadone dose increases were double blind. Vouchers had monetary value and were exchangeable for goods and services. Groups not receiving contingent vouchers received matching vouchers independent of urine test results. Primary outcome measure was opiate-negative urine specimens (thrice weekly urinalysis).

Results  Contingent vouchers and a methadone dose increase each significantly increased the percentage of opiate-negative urine specimens during intervention. Contingent vouchers, with or without a methadone dose increase, increased the duration of sustained abstinence as assessed by urine screenings. Methadone dose increase, with or without contingent vouchers, reduced self-reported frequency of use and self-reported craving.

Conclusions  In patients enrolled in a methadone-maintainence program who continued to use heroin, abstinence reinforcement and a methadone dose increase were each effective in reducing use. When combined, they did not dramatically enhance each other's effects on any 1 outcome measure, but they did seem to have complementary benefits.


From the National Institute on Drug Abuse Intramural Research Program, Baltimore, Md.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Effects of Lower-Cost Incentives on Stimulant Abstinence in Methadone Maintenance Treatment: A National Drug Abuse Treatment Clinical Trials Network Study
Peirce et al.
Arch Gen Psychiatry 2006;63:201-208.
ABSTRACT | FULL TEXT  

Six-Month Trial of Bupropion With Contingency Management for Cocaine Dependence in a Methadone-Maintained Population
Poling et al.
Arch Gen Psychiatry 2006;63:219-228.
ABSTRACT | FULL TEXT  

National survey of methadone prescribing for maintenance treatment: 'opiophobia' among substance misuse services?
Joseph and Moselhy
Psychiatr. Bull. 2005;29:459-461.
ABSTRACT | FULL TEXT  

Effect of Prize-Based Incentives on Outcomes in Stimulant Abusers in Outpatient Psychosocial Treatment Programs: A National Drug Abuse Treatment Clinical Trials Network Study
Petry et al.
Arch Gen Psychiatry 2005;62:1148-1156.
ABSTRACT | FULL TEXT  

Treating Opioid Dependence: Growing Implications for Primary Care
Krantz and Mehler
Arch Intern Med 2004;164:277-288.
ABSTRACT | FULL TEXT  

What works in drug addiction?
Luty
Adv. Psychiatr. Treat. 2003;9:280-288.
ABSTRACT | FULL TEXT  

Treating Opioid Dependence -- New Data and New Opportunities
O'Connor
NEJM 2000;343:1332-1334.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.